Villegas I, Martín M J, La Casa C, Motilva V, Alarcón de la Lastra C
Department of Pharmacology, Faculty of Pharmacy, University of Sevilla, Spain.
Inflamm Res. 2000 Jul;49(7):361-6. doi: 10.1007/PL00000217.
In addition to a deficiency of endogenous prostaglandins due to inhibition of cyclo-oxygenase and a host of prostaglandin-mediated effects on mucosal protection, it has recently been proposed that neutrophil- and oxygen radical - dependent microvascular injuries may be important prime events that lead to mucosal injury induced by non-steroidal anti-inflammatory drugs. Therefore, we evaluated the role of oxygen free radicals in the pathogenesis of acute gastric ulceration induced by meloxicam, a preferential COX-2 inhibitor.
Studies were performed in Wistar rats.
Meloxicam was given by oral administration (3.75-30 mg/kg body weight).
Determinations were made of gastric mucosal injury, xanthine-oxidase, myeloperoxidase and superoxide dismutase activities, as well as the effect of meloxicam on gastric prostaglandin synthesis (PGE2 levels) and glutathione homeostasis.
Oral administration of meloxicam dose-dependently (3.75-30 mg/kg) caused acute gastric haemorrhage erosions. The total area of gastric lesions increased with time until 24 hours after dosing. Xanthine-oxidase activity increased significantly after administration of the drug. Myeloperoxidase activity, as an index of neutrophil infiltration, as well as glutathione peroxidase, an important enzyme that scavenges lipid peroxides, were unaffected by meloxicam administration. In addition, superoxide dismutase activity, PGE2 and glutathione levels were significantly reduced.
These results support the hypothesis that in addition to suppression of prostaglandin synthesis, oxygen free radicals, probably derived via the action of xanthine oxidase, the decrease in superoxide dismutase activity, and the depletion of mucosal glutathione contribute to the pathogenesis of meloxicam-induced ulceration.
除了因环氧化酶受抑制导致内源性前列腺素缺乏以及一系列前列腺素介导的黏膜保护作用外,最近有人提出,中性粒细胞和氧自由基依赖性微血管损伤可能是导致非甾体抗炎药引起黏膜损伤的重要起始事件。因此,我们评估了氧自由基在美洛昔康(一种选择性COX - 2抑制剂)所致急性胃溃疡发病机制中的作用。
在Wistar大鼠身上进行研究。
通过口服给予美洛昔康(3.75 - 30毫克/千克体重)。
测定胃黏膜损伤、黄嘌呤氧化酶、髓过氧化物酶和超氧化物歧化酶活性,以及美洛昔康对胃前列腺素合成(PGE2水平)和谷胱甘肽稳态的影响。
口服美洛昔康(3.75 - 30毫克/千克)剂量依赖性地引起急性胃出血性糜烂。胃损伤总面积随时间增加,直至给药后24小时。给药后黄嘌呤氧化酶活性显著增加。作为中性粒细胞浸润指标的髓过氧化物酶活性以及清除脂质过氧化物的重要酶谷胱甘肽过氧化物酶,不受美洛昔康给药的影响。此外,超氧化物歧化酶活性、PGE2和谷胱甘肽水平显著降低。
这些结果支持以下假说,即除了抑制前列腺素合成外,可能通过黄嘌呤氧化酶作用产生的氧自由基、超氧化物歧化酶活性降低以及黏膜谷胱甘肽耗竭,都有助于美洛昔康诱导溃疡的发病机制。